Pharmacy Compounding of Personalized Preparation for Specific Patients: Challenges and Advantages, 2nd Edition

Dear Colleagues,

The compounding of extemporaneous preparations has historically been a valuable part of the pharmacist profession, and even today, its usefulness is recognized in all regulatory frameworks worldwide. The possibility to prepare personalized medicines in a hospital or community pharmacy is indeed very beneficial to satisfying therapeutic needs unmet by industrially manufactured medicinal products. It makes it possible to vary the quantity of each active ingredient within a preparation, as well as use combined substances, which can be more efficient if mixed. The ability to personalize dosages is particularly useful when treating age groups with different needs, e.g., children and the elderly. It is also useful when treating patients suffering from neoplasia or degenerative diseases that can cause a range of conditions and pain. The possibility to dispose of compounded drugs is also fundamental in the veterinary field, where there are often no registered products on the market for a determined affection in an animal species.

This Special Issue of Pharmaceutics focuses on articles and reviews relating to formulations intended to meet the needs of specific patient populations—both human and veterinary. Particular attention will be paid to studies related to the selection of the most suitable components, the evaluation of their compatibility and stability, the development of standard operating procedures for the preparation and manipulation, and the quality assurance of the formulations.

We look forward to receiving your contributions.

Dr. Francesca Baratta
Dr. Paola Brusa
Prof. Dr. Paola Minghetti
Dr. Umberto Musazzi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.